Intravascular Ultrasound Market Report 2025 (Global Edition)

Global Intravascular Ultrasound Market Report 2025 Market Size Split by Type (Accessories, IVUS Consoles, IVUS Catheters), by End-user (Hospitals, Specialty Clinics)

Intravascular Ultrasound Market Report Description

We have various report editions of Intravascular Ultrasound Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape
The global intravascular ultrasound (IVUS) market is moderately consolidated, with competition centered on innovation in imaging precision, catheter design, and AI-driven procedural guidance. Leading companies are prioritizing platform integration, automation, and clinical workflow optimization to differentiate themselves. Collaborations between device manufacturers and research institutions are accelerating the development of hybrid systems that combine IVUS with complementary modalities like iFR and OCT. Additionally, companies are investing in AI-based image interpretation and cloud-enabled platforms to improve diagnostic accuracy and expand access. This innovation race is being shaped by growing clinical demand for precision-guided cardiovascular interventions and regional preferences for advanced imaging systems.

Recent Developments in the Intravascular Ultrasound (IVUS) Market

• Introduction of Philips Cardiac Workstation in EMEA

In June 2024, Philips launched its new Cardiac Workstation across Europe, the Middle East, and Africa (EMEA). This platform utilizes advanced algorithms to access, analyze, and manage electrocardiograph (ECG) data, either remotely or at the point of care. By streamlining data collection and reducing administrative workload, the Cardiac Workstation aims to enhance diagnostic cardiology, allowing clinicians to prioritize at-risk patients more effectively. This innovation reflects a broader trend towards integrating artificial intelligence in healthcare to improve patient outcomes and operational efficiency. 
(Source: https://www.philips.com/a-w/about/news/archive/standard/news/press/2024/philips-aims-to-transform-diagnostic-cardiology-with-introduction-of-new-cardiac-workstation.html) 

• Boston Scientific's AVVIGO+ Multi-Modality Guidance System Receives FDA Clearance

In September 2023, Boston Scientific announced that its AVVIGO+ Multi-Modality Guidance System received clearance from the U.S. Food and Drug Administration (FDA). This next-generation system integrates intravascular ultrasound (IVUS) and fractional flow reserve (FFR) technologies, enhanced by artificial intelligence (AI) capabilities through its Automated Lesion Assessment software. The system is designed to automate key procedural steps, provide precise vessel measurements, and expedite the acquisition of IVUS images during percutaneous coronary interventions (PCI). By streamlining these processes, the AVVIGO+ system aims to improve procedural efficiency and patient outcomes in the treatment of coronary artery disease. This development underscores the industry's shift towards integrating AI to enhance diagnostic precision and procedural workflows in cardiovascular interventions. 

(Source: https://citoday.com/news/boston-scientifics-avvigo-guidance-system-receives-fda-clearance-and-ce-mark-approval 
Boston Scientific launches AVVIGO+ Multi-Modality Guidance System in India - IndiaMedToday
https://www.healio.com/news/cardiology/20230927/boston-scientific-announces-fda-clearance-of-nextgeneration-pci-guidance-system)
 

Top Companies Market Share in Intravascular Ultrasound Industry: (In no particular order of Rank)

• Boston Scientific Corporation 
• Koninklijke Philips N.V.
• Terumo Corporation 
• Infraredx Inc.
• ACIST Medical Systems
• Siemens Medical Solutions USA
• Inc.
• Conavi Medical
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Which Region Dominates the Market?

North America currently dominates the global intravascular ultrasound (IVUS) market, driven by its well-established healthcare infrastructure, high procedural volumes in interventional cardiology, and a proactive stance on adopting imaging-guided interventions. The region accounts for a substantial share of the global market due to a combination of clinical demand, supportive policy frameworks, and strong presence of leading medical device companies.
A key driver of this regional dominance is the high prevalence of cardiovascular diseases (CVDs), which remain the leading cause of death in the United States. Upon reviewing the available data, the Centers for Disease Control and Prevention (CDC) reports that approximately 4.8% of U.S. adults have ever been diagnosed with coronary heart disease as of 2023. This statistic is based on data from the National Health Interview Survey for the years 2019–2023, creating a robust and ongoing need for advanced diagnostic imaging tools such as IVUS to support effective diagnosis and intervention.
(Source: https://www.cdc.gov/nchs/fastats/heart-disease.htm) 
Furthermore, the American College of Cardiology (ACC) has played a pivotal role in promoting intravascular imaging adoption. In 2023, the ACC issued updated recommendations encouraging the routine use of IVUS or OCT in percutaneous coronary interventions (PCIs), particularly for complex lesions or left main disease. These guidelines are pushing hospitals and cardiology centers to incorporate IVUS into procedural standards.
(Source: Cardiovascular Business – ACC Guidelines)
In addition to clinical needs, technological innovation and integration are also driving market leadership in North America. Companies like Philips and Boston Scientific have introduced advanced AI-powered IVUS platforms that streamline workflow, enhance diagnostic clarity, and reduce interpretation variability. Many of these systems are being piloted or commercialized first in the U.S. due to faster regulatory clearance processes and greater investment in digital health infrastructure.
Reimbursement frameworks and bundled payment models that reward outcomes-based care are also supporting the use of imaging-guided interventions. Hospitals are incentivized to reduce re-intervention rates and improve procedural outcomes—both of which IVUS directly supports.
In summary, North America’s dominance in the IVUS market is the result of a unique blend of clinical demand, policy support, advanced infrastructure, and innovation readiness, positioning the region at the forefront of global adoption. As cardiovascular care continues to shift toward precision-based, minimally invasive interventions, North America is expected to maintain its leadership throughout the forecast period.
 (Source: Cardiovascular Business)

Which is the Fastest Growing Region in the Market?
Asia-Pacific is emerging as the fastest-growing region in the intravascular ultrasound (IVUS) market, fuelled by the rapid increase in cardiovascular disease (CVD) prevalence, expanding healthcare infrastructure, and rising adoption of advanced interventional imaging technologies. Countries such as Japan, China, and India are playing pivotal roles in driving regional demand, with both public and private sectors investing heavily in digital cardiology solutions.
Japan leads the region—and much of the world—in per capita IVUS usage. Over 80% of percutaneous coronary interventions (PCIs) performed in Japanese hospitals utilize IVUS, largely due to government reimbursement policies and a long-standing clinical preference for imaging-guided interventions. A 2023 review published by the Japanese Circulation Society attributes Japan’s leadership in IVUS adoption to its early clinical integration, investment in operator training, and support for precision-guided therapy.
(Source: PubMed Central – IVUS in Japan)
Meanwhile, China is experiencing exponential growth in cardiovascular imaging as part of its national “Healthy China 2030” strategy. The country has invested in upgrading over 1,500 hospitals with advanced catheterization labs and is encouraging digital imaging adoption through government funding and local innovation. In 2024, several Chinese hospitals partnered with device manufacturers to integrate AI-powered IVUS systems into cardiac centers, particularly in urban Tier 1 and Tier 2 cities.
(Source: Regulatory responses and approval status of artificial intelligence medical devices with a focus on China - PubMed)
India is also witnessing growing uptake of IVUS technology, supported by a surge in private-sector cardiac specialty centers and increased procedural volumes related to coronary artery disease. While access remains limited in rural areas, urban hospitals are adopting imaging-guided PCI to improve procedural outcomes and reduce stent-related complications.
(Source: 3734_pdf.pdf)
In summary, Asia-Pacific is positioning itself as a dynamic growth hub for the IVUS market. The combination of high disease burden, government-backed modernization efforts, and clinical advocacy for image-guided cardiology continues to push the region forward. As reimbursement models evolve and clinician training expands, Asia-Pacific is expected to account for an increasing share of global IVUS procedures in the years ahead.
(Source: PMC)
 

The current report Scope analyzes Intravascular Ultrasound Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

Intravascular Ultrasound Market Analysis

The IVUS market is primarily segmented into two major product types: IVUS consoles and IVUS catheters. Consoles serve as the core imaging workstations used to process, display, and store real-time vascular images, while catheters are disposable, miniaturized ultrasound probes inserted into the blood vessels during a procedure. Among these, IVUS catheters dominate the product segment due to their indispensable role in every intravascular ultrasound examination. These catheters contain high-frequency transducers that emit and receive ultrasound signals as they travel through the artery, generating detailed images of the vessel wall. Their precision is critical in determining lesion severity, plaque morphology, and stent sizing during percutaneous coronary interventions (PCI). Leading manufacturers such as Boston Scientific and Terumo have introduced advanced catheters with improved flexibility, imaging resolution, and compatibility with rapid-exchange systems to simplify procedural workflows. For instance, Boston Scientific’s OptiCross HD catheter is engineered for high-resolution imaging, particularly in tortuous and calcified vessels, enhancing physician confidence during complex interventions.
(Source: OPTICROSS™ HD Coronary Imaging Catheters – Boston Scientific)
The continued evolution of catheter design is directly influencing the accuracy, efficiency, and clinical outcomes of IVUS-guided therapies.
 

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Intravascular Ultrasound Industry. Request a Free Sample PDF!

The IVUS market is segmented by end-use into hospitals and specialty clinics. Hospitals represent the largest end-user category, as they house the infrastructure, cardiac catheterization labs, and trained personnel necessary for advanced cardiovascular procedures. However, hospitals remain the primary and most critical users of IVUS systems, especially for complex cases requiring high procedural precision and imaging-guided intervention. These institutions often participate in large-scale clinical trials and implement advanced imaging protocols as part of their interventional cardiology services. As reimbursement policies evolve to support quality-focused care, hospitals are further incentivized to use intravascular imaging to minimize post-procedural complications and readmission rates. Tertiary-care centers in countries like the U.S., Germany, and Japan are key hubs for IVUS utilization, offering integrated platforms that combine IVUS with other diagnostic modalities such as optical coherence tomography (OCT) or fractional flow reserve (FFR). For instance, Mayo Clinic’s cardiovascular division employs hybrid IVUS-OCT systems for both diagnostic and interventional purposes, aligning with global trends in precision-guided cardiovascular therapy.
(Source: Cardiovascular Medicine - Department home - Mayo Clinic)
Specialty clinics, while growing in number, typically lack the full-scale imaging infrastructure seen in hospital settings but are expected to become more prominent as outpatient cardiac care continues to expand.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion